Safa et al. observed a significant reduction in the expression of the lncRNAs SPRY4-IT1, HOXA-AS2, LINC-ROR, and MEG3 in female MS patients compared to healthy women. This evidence concerns the gene LINC-ROR and myeloid sarcoma.